Inhibitors of L2 mediated cell adhesion

   
   

The present invention relates to a compound of the following formula: ##STR1##

or a pharmaceutically acceptable salt thereof. Also disclosed are compositions containing the compound and methods of preparing and using the compounds. The compounds of the invention are useful in treating L2 adhesion mediated conditions in a mammal.

 
Web www.patentalert.com

< Anti-tissue factor antibodies with enhanced anticoagulant potency

< Labelled factor XIIIa substrates

> Pyridoxine and pyridoxal analogues: new uses

> MMP-12 inhibitors

~ 00183